News and Trends 18 Aug 2022Patients with beta-thalassemia able to access first approved gene therapy A gene therapy drug approved by the U.S. Food and Drug Administration (FDA) has been made accessible for people with… August 18, 2022 - 3 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
In Depth 11 Oct 2021A Cure for Cancer? How CAR-T Cell Therapy is Revolutionizing Oncology CAR-T therapy has been hailed as a cure for cancer, but what really is this ‘miraculous technology’ and what can… October 11, 2021 - 10 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 4 May 2021Bluebird Bio Withdrawal Raises Gene Therapy Doubts in Europe Last month, the US firm bluebird bio abandoned the sale of its gene therapy Zynteglo in Germany after a pricing… May 4, 2021 - 5 minutesmins - By Anita Chakraverty Share WhatsApp Twitter Linkedin Email
News and Trends 14 Jan 2020Bluebird Bio Launches First Gene Therapy for Beta Thalassemia in Germany The US company bluebird bio has launched the first gene therapy for the blood disorder transfusion-dependent beta thalassemia in the… January 14, 2020 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
More News! 9 Oct 2019Novo Nordisk and Bluebird Bio to Treat Hemophilia with Gene Editing The Danish big pharma Novo Nordisk has joined forces with the US gene therapy company bluebird bio to develop next-generation… October 9, 2019 - 1 minutemin - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 14 Jun 2019First Gene Therapy for Beta Thalassemia Will Cost Over €1.5M Zynteglo, a gene therapy developed by the US company bluebird bio for the treatment of beta-thalassemia, will cost European healthcare… June 14, 2019 - 1 minutemin - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 4 Jun 2019First Gene Therapy for Beta Thalassemia Approved in Europe The US biotech company bluebird bio has obtained EU conditional market approval for a gene therapy that could remove the… June 4, 2019 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 20 Apr 2018Gene Therapy For Beta-Thalassemia Could Eliminate Need for Transfusions Bluebird bio has obtained results from two clinical studies showing its new gene therapy could eliminate the need for red blood… April 20, 2018 - 2 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
News and Trends 7 Dec 2017Scottish Biotech and Bluebird Bio to Develop Next Generation CAR-T Cells TC Biopharm has scored a deal with bluebird bio for the development of the next generation of CAR-T cells, a… December 7, 2017 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 26 Dec 2016The Largest Deals, Fundraising and Exits of 2016 in European Biotech Curious about which technologies have attracted the most cash in biotech finance this year? Here's a list of the most impressive cash… December 26, 2016 - 5 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 14 Dec 2016What do the CAR-T Patient Deaths Mean for the Future of the Field? Juno’s JCAR015 study came to a halt for the second time this year after two more patient deaths. But despite… December 14, 2016 - 7 minutesmins - By Diana Kwon Share WhatsApp Twitter Linkedin Email
News and Trends 22 Sep 2015UniQure’s cure for rare Lysosomal disease ready for phase III trial UniQure from the Netherlands has promising results for its enzyme replacement therapy phase Ib/II trial targeting a rare Lysosomal disease.… September 22, 2015 - 3 minutesmins - By Dani Bancroft Share WhatsApp Twitter Linkedin Email
News and Trends 18 Jun 2015German Viral Vector Producer SIRION pursues its American dream and opens in Boston The biggest biocluster of the World is still attractive. Munich-based Sirion Biotech decided to open an office to establish its… June 18, 2015 - 2 minutesmins - By Philip Hemme Share WhatsApp Twitter Linkedin Email
News and Trends 8 May 2015GSK sparks off the Gene Therapy resurgence GlaxoSmithKline has become the first big pharma company to file a gene therapy approval case to the European Medicines Agency (EMA). The… May 8, 2015 - 4 minutesmins - By Joachim Eeckhout Share WhatsApp Twitter Linkedin Email
News and Trends 10 Mar 2015Live from Bio-Europe 2015: The product development challenges in the gene therapy field Gene Therapy is really the hot topic right now in the field of Biotech especially with technologies such as CRISPR and… March 10, 2015 - 3 minutesmins - By Philip Hemme Share WhatsApp Twitter Linkedin Email
News and Trends 5 Dec 2014Forbion Capital Partners: a Leading European Biotech VC is rising! Forbion Capital Partners, the leading Dutch Venture Capital firm investing in world-class healthcare technologies, sold PneumRx of its portfolio, to BTG plc,… December 5, 2014 - 3 minutesmins - By Julie Lellouche Share WhatsApp Twitter Linkedin Email
News and Trends 1 Dec 2014The First Gene Therapy Drug Will Be Sold at Record €1,1M Price What could you buy with €1,1M euros? A house? Or a single prescription for a new drug... The first gene therapy drug… December 1, 2014 - 3 minutesmins - By Julie Lellouche Share WhatsApp Twitter Linkedin Email
News and Trends 17 Oct 2014Should European Biotech CEOs wear more sneakers? Today is Friday or Casual Day. Did you leave the suit and the tie at home to wear jeans and sneakers? Should… October 17, 2014 - 3 minutesmins - By Philip Hemme Share WhatsApp Twitter Linkedin Email